Relative survival following response to 7+3 versus azacytidine is similar in acute myeloid leukemia and high-risk myelodysplastic syndromes:An analysis of four SWOG studies

Here we quantify and compare the absolute and relative overall survival (OS) benefits conveyed by complete remission (CR) in AML and high-risk MDS, and by CR with incomplete count recovery (CRi) in AML and by hematologic improvement (HI) in MDS, following treatment with 7+3 versus azacytidine. We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Othus, Megan, Sekeres, Mikkael A., Nand, Sucha, Garcia-Manero, Guillermo, Appelbaum, Frederick R., Erba, Harry P., Estey, Eli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367029/
https://www.ncbi.nlm.nih.gov/pubmed/30315234
http://dx.doi.org/10.1038/s41375-018-0275-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367029/
https://www.ncbi.nlm.nih.gov/pubmed/30315234
http://dx.doi.org/10.1038/s41375-018-0275-x

Ejemplares similares